R3 ENTERPRISES, LLC is a holding company, business advisory, operations and general management practice founded in 2003. As Business Advisors we work with venture capital portfolio companies, early stage pharma and healthcare companies, universities, and biopharma and healthcare organizations. R3 ENTERPRISES sources, performs due diligence, negotiates agreements, and facilitates acquisition and commercial development of early stage biopharma assets. Including: small molecules, antibodies, proteins, and nucleotides. We have been successful at leading strategy formation, market development, and complex program and deal execution within corporate and entrepreneurial environments. R3 ENTERPRISES's experience includes more than 15 years leading domestic and international pharmaceutical drug development, clinical research, marketing, and sales. Beyond pharmaceuticals, our chairman has more than 15 years experience leading new venture development, company acquisition, multi-unit and multi-state operations, and commercial real estate development.